Content area

|
|

Gastrisk aspirationsbehandling er et muligt alternativ til behandling af fedme

Forfatter(e)
Marie Møller Christensen1, Tina Jorsal1, Lars Peter Skat Naver2, Tina Vilsbøll1 & Filip Krag Knop1 1) Center for Diabetesforskning, Gentofte Hospital 2) Privathospitalet Møn Ugeskr Læger 2017;179:V03170198
Reference: 
Ugeskr Læger 2017;179:V03170198
Blad nummer: 
Sidetal: 
2-5
Gastric aspiration therapy is a possible alternative to treatment of obesity
Aspiration therapy with AspireAssist is a novel endoscopic obesity treatment. Patients aspirate about 30% of an ingested meal through a draining system via a percutanous endoscopic gastrostomy tube. AspireAssist was recently approved by the FDA, and it induces weight loss comparable to bariatric surgery but with a lower risk. Few clinical studies about the efficacy/safety of AspireAssist have been carried out, so further intervention studies evaluating acute and long-term effects are warranted.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Knud Raben-Pedersen | 21/09
6 kommentarer
af Peter Matzen | 21/09
1 Kommentar
af Finn Vallø Hansen | 21/09
1 Kommentar
af Johan Ludvig Reventlow | 19/09
2 kommentarer
af Andreas Gothardt Lundh | 17/09
1 Kommentar
af Bjørn Søeberg | 17/09
33 kommentarer
af Lene Annette Norberg | 15/09
5 kommentarer
af Søren Holm | 14/09
1 Kommentar